ArticleBreast cancer research : BCR2024

Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial.

Nianhua Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.